References
- Anderson BO, Shyyan R, Eniu A, et al (2006). Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines. Breast J, 12, 3-15. https://doi.org/10.1111/j.1075-122X.2006.00199.x
- Ashikaga T, Krag DN, Land SR, et al (2010). Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol, 102, 111-8. https://doi.org/10.1002/jso.21535
- Balch CM, Singletary SE, Bland KI (1993). Clinical decision-making in early breast cancer. Ann Surg, 217, 207-25.
- Bai YL, Zhou B, Jing XY, et al (2012).Predictive Role of GSTs on the Prognosis of Breast Cancer Patients with Neoadjuvant Chemotherapy. Asian Pac J Cancer Prev, 13, 5019-22. https://doi.org/10.7314/APJCP.2012.13.10.5019
- Chan DN, Lui LY, So WK (2010). Effectiveness of exercise programmes on shoulder mobility and lymphoedema after axillary lymph node dissection for breast cancer: systematic review. J Adv Nurs, 66, 1902-14.
- Deckers PJ (1991). Axillary dissection in breast cancer: when, why, how much, and for how long? Another operation soon to be extinct? J Surg Oncol, 48, 217-9. https://doi.org/10.1002/jso.2930480402
- Dees EC, Shulman LN, Souba WW, et al (1997). Does information from axillary dissection change treatment in clinically node-negative patients with breast cancer? An algorithm for assessment of impact of axillary dissection. Ann Surg, 226, 279-86. https://doi.org/10.1097/00000658-199709000-00007
- Eberlein TJ (1994). Current management of carcinoma of the breast. Ann Surg, 220, 121-36. https://doi.org/10.1097/00000658-199408000-00003
- Fisher B, Anderson S, Redmond CK, et al (1995). Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med, 333, 1456-61. https://doi.org/10.1056/NEJM199511303332203
- Fisher B, Bauer M, Wickerham DL, et al (1983). Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer: An NSABP update. Cancer, 52, 1551-7. https://doi.org/10.1002/1097-0142(19831101)52:9<1551::AID-CNCR2820520902>3.0.CO;2-3
- Fisher B, Jeong JH, Anderson S, et al (2002). Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med, 347, 567-75. https://doi.org/10.1056/NEJMoa020128
- Fisher B, Redmond C, Fisher ER, et al (1985). Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med, 312, 674-81. https://doi.org/10.1056/NEJM198503143121102
- Fisher B, Wolmark N, Bauer M, et al (1981). The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet, 152, 765-72.
- Halsted WS (1907). The results of radical operations for the cure of cancer of the breast. Ann Surg, 46, 1-5. https://doi.org/10.1097/00000658-190707000-00001
- Harris JR, Osteen RT (1985). Patients with early breast cancer benefit from effective axillary treatment. Breast Cancer Res Treat, 5, 17-21. https://doi.org/10.1007/BF01807645
- IBCSG, Rudenstam CM, Zahrieh D, et al (2006). Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International. J Clin Oncol, 4, 337-40.
- Gardner B, Feldman J (1993). Are positive axillary nodes in breast cancer markers for incurable disease? Ann Surg, 218, 270-8. https://doi.org/10.1097/00000658-199309000-00006
- Krag DN, Anderson SJ, Julian TB, et al (2010). Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol, 11, 927-33. https://doi.org/10.1016/S1470-2045(10)70207-2
- Liljegren G, Holmberg L (1997). Arm morbidity after sector resection and axillary dissection with and without postoperative radiotherapy in breast cancer stage I: Results from a randomized trial. Uppsala-Orebro Breast Cancer Study Group. Eur J Cancer, 33, 193-9. https://doi.org/10.1016/S0959-8049(96)00375-9
- Lythgoe JP, Palmer MK (1982). Manchester regional breast study ? 5 and 10 year results. Br J Surg, 69, 693-6. https://doi.org/10.1002/bjs.1800691202
- Martelli G, Boracchi P, De Palo M, et al (2005). Randomized trial comparing axillary dissection to no axillary dissection in older patients with T1N0 breast cancer: results after 5 years of follow-up. Ann Surg, 242, 1-6. https://doi.org/10.1097/01.sla.0000167759.15670.14
- NIH consensus conference (1991). Treatment of early-stage breast cancer. JAMA, 265, 391-4. https://doi.org/10.1001/jama.1991.03460030097037
- Parmigiani G, Berry DA, Winer EP, et al (1999). Is axillary lymph node dissection indicated for early stage breast cancer? A decision analysis. J Clin Oncol, 17, 1465-73.
- Pepels MJ, Vestjens JH, de Boer M, et al (2011). Safety of avoiding routine use of axillary dissection in early stage breast cancer: a systematic review. Breast Cancer Res Treat, 125, 301-13. https://doi.org/10.1007/s10549-010-1210-7
- Ribeiro GG, Magee B, Swindell R, et al (1993). The Christie Hospital breast conservation trial: an update at 8 years from inception. Clin Oncol (R Coll Radiol), 5, 278-83. https://doi.org/10.1016/S0936-6555(05)80900-8
- Ruffin WK, Stacey-Clear A, Younger J, et al (1995). Rationale for routine axillary dissection in carcinoma of the breast. J Am Coll Surg, 180, 245-51.
- Siesling S, van Dijck JA, Visser O, et al (2003). Trends in incidence of and mortality from cancer in The Netherlands in the period 1989-1998. Eur J Cancer, 39, 2521-30. https://doi.org/10.1016/S0959-8049(03)00622-1
- Silverstein MJ, Gierson ED, Waisman JR, et al (1994). Axillary lymph node dissection for T1a breast carcinoma: Is it indicated? Cancer, 73, 664 -7. https://doi.org/10.1002/1097-0142(19940201)73:3<664::AID-CNCR2820730326>3.0.CO;2-S
- Smith JA 3rd, Gamez-Araujo JJ, Gallager HS, et al (1990). Carcinoma of the breast: analysis of total lymph node involvement versus level of metastasis. Cancer, 39, 527-32.
- Sofi GN, Sofi JN, Nadeem R, et al (2012). Estrogen receptor and Progesterone Receptor Status in Brast Cancer in Relation to Age, Histological Grade, Size of Lesion and Lymph Node Involvement. Asian Pac J Cancer Prev, 13, 5047-52. https://doi.org/10.7314/APJCP.2012.13.10.5047
- Tian JH, Li L, Liu AP, et al (2012). Same Topic of systematic Reviews,Same Conclusion? Asian Pac J Cancer Prev, 13, 5325. https://doi.org/10.7314/APJCP.2012.13.10.5325
- Veronesi U, Paganelli G, Viale G, et al (2003). A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med, 349, 546-53. https://doi.org/10.1056/NEJMoa012782
Cited by
- Meta-analysis to determine the clinical impact of axillary lymph node dissection in the treatment of invasive breast cancer vol.153, pp.2, 2015, https://doi.org/10.1007/s10549-015-3549-2
- Does the number of removed axillary lymphnodes in high risk breast cancer patients influence the survival? vol.19, pp.1, 2019, https://doi.org/10.1186/s12885-019-5292-2